Alx Oncology Holdings (ALXO) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | -61.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.15% |
| Dec 31, 2025 | -58.69% |
| Sep 30, 2025 | -56.59% |
| Jun 30, 2025 | -54.86% |
| Mar 31, 2025 | -21.45% |
| Dec 31, 2024 | -19.06% |
| Sep 30, 2024 | -13.96% |
| Jun 30, 2024 | -13.38% |
| Mar 31, 2024 | -12.49% |
| Dec 31, 2023 | -7.71% |
| Sep 30, 2023 | 54.84% |
| Jun 30, 2023 | 134.85% |
| Mar 31, 2023 | 193.87% |
| Dec 31, 2022 | 333.56% |
| Sep 30, 2022 | 315.66% |
| Jun 30, 2022 | 876.05% |
| Mar 31, 2022 | 2,746.81% |
| Dec 31, 2021 | 1,625.00% |
| Sep 30, 2021 | 1,148.89% |
| Jun 30, 2021 | -72.17% |
| Dec 31, 2020 | -93.95% |